封面
市场调查报告书
商品编码
1620607

免疫保健补充剂市场机会、成长动力、行业趋势分析和预测 2024 - 2032

Immune Health Supplements Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 145 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年,全球免疫健康补充剂市场估值为 253 亿美元,预计 2024 年至 2032 年将以 9.8% 的年复合成长率(CAGR) 增长。矿物质、草药和其他成分,旨在增强免疫功能,减少疾病的严重程度和持续时间,并促进整体健康。该市场成长的主要动力是慢性病盛行率的增加,导致对免疫保健补充剂的需求增加。随着慢性病患者寻求增强免疫系统的方法,市场不断扩大。此外,健康意识的增强,尤其是老龄化人口的健康意识的增强,进一步推动了这项需求。

老年人更容易出现免疫力下降的情况,因此越来越多地转向补充剂作为预防性健康措施。补充剂配方的创新也有助于市场成长。这些进步可以提供更有针对性和更有效的免疫支持,将免疫保健补充剂定位为主动医疗保健策略的重要组成部分。就产品类型而言,市场分为维生素、矿物质补充剂、草药补充剂、益生菌、氨基酸、omega-3 脂肪酸和电解质等类别。

维生素领域在 2023 年价值达 73 亿美元,在市场中占据主导地位,预计将继续成长。众所周知,必需维生素 A、C、D 和 E 在支持免疫功能方面发挥着至关重要的作用,因此备受追捧。从剂型来看,市场分为胶囊剂、锭剂、粉末剂、液体剂等。胶囊到 2023 年将占据 34.2% 的市场份额,预计将大幅成长。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 253亿美元
预测值 580 亿美元
复合年增长率 9.8%

它们提供更好的生物利用度,使营养物质更快被吸收到血液中。某些胶囊配方也设计用于延迟或定向释放,确保活性成分在消化系统内的最佳点被吸收。从地区来看,北美预计将主导免疫保健品市场,预计到 2032 年该地区将达到 232 亿美元。糖尿病、癌症和自体免疫疾病等慢性病的高发生率是推动该地区需求的重要因素。

监管监督确保这些产品符合安全和标籤标准,进一步增强消费者对现有补充剂的功效和品质的信心。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 慢性病盛行率上升
      • 提高健康意识
      • 老年人口不断增加
      • 补充剂配方的创新
    • 产业陷阱与挑战
      • 高级补充剂相关的高成本
      • 潜在的副作用
  • 成长潜力分析
  • 监管环境
  • 技术景观
  • 未来市场趋势
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章:市场估计与预测:按产品类型,2021 - 2032 年

  • 主要趋势
  • 维生素
    • 维生素A
    • 复合维生素B
    • 维生素C
    • 维生素D
    • 维生素E
    • 维生素K
  • 矿物质补充剂
    • 锌补充剂
    • 铁补充剂
    • 镁补充剂
    • 其他矿物质补充剂
  • 草药补充剂
  • 益生菌补充剂
  • 胺基酸和蛋白质
  • 欧米伽3脂肪酸
  • 电解质补充剂

第 6 章:市场估计与预测:按配方划分,2021 - 2032 年

  • 主要趋势
  • 胶囊
  • 平板电脑
  • 粉末
  • 液体
  • 其他配方

第 7 章:市场估计与预测:按来源类型,2021 - 2032 年

  • 主要趋势
  • 自然的
  • 合成的

第 8 章:市场估计与预测:以用药方式划分,2021 - 2032 年

  • 主要趋势
  • 处方
  • 场外交易 (OTC)

第 9 章:市场估计与预测:按配销通路,2021 - 2032 年

  • 主要趋势
  • 线下零售店
    • 药局和药局
    • 大型超市/超市
    • 便利商店
  • 网路零售店

第 10 章:市场估计与预测:按地区,2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章:公司简介

  • Abbott Laboratories
  • American Health
  • Amway
  • Bayer
  • Cargill
  • Danone
  • Herbalife Nutrition of America
  • Himalaya Global Holdings
  • MegaFood
  • Metagenics
  • Nordic Naturals
  • NOW Foods
  • Nestle
  • Swisse Wellness
  • The Nature's Bounty
简介目录
Product Code: 11937

The Global Immune Health Supplements Market was valued at USD 25.3 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2032. These supplements, designed to support the immune system, include a range of vitamins, minerals, herbs, and other ingredients that aim to enhance immune function, reduce the severity and duration of illness, and promote overall health. A major driver behind this market's growth is the increasing prevalence of chronic diseases, leading to greater demand for immune health supplements. As individuals with chronic conditions seek ways to strengthen their immune systems, the market continues to expand. Additionally, growing health awareness, particularly among aging populations, further fuels this demand.

The elderly, being more prone to immune decline, are increasingly turning to supplements as a preventive health measure. Innovations in supplement formulations are also contributing to market growth. These advancements allow for more targeted and effective immune support, positioning immune health supplements as essential components of proactive healthcare strategies. In terms of product types, the market is segmented into categories like vitamins, mineral supplements, herbal supplements, probiotics, amino acids, omega-3 fatty acids, and electrolytes.

The vitamins segment, valued at USD 7.3 billion in 2023, dominated the market and is expected to continue growing. Essential vitamins like A, C, D, and E are known to play a crucial role in supporting immune function, making them highly sought-after. When looking at formulations, the market is categorized into capsules, tablets, powder, liquid, and others. Capsules, which held a 34.2% market share in 2023, are anticipated to see substantial growth.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$25.3 Billion
Forecast Value$58 Billion
CAGR9.8%

They offer better bioavailability, allowing nutrients to be absorbed more quickly into the bloodstream. Certain capsule formulations are also designed for delayed or targeted release, ensuring that the active ingredients are absorbed at optimal points within the digestive system. Regionally, North America is expected to dominate the immune health supplements market, with the region forecasted to reach USD 23.2 billion by 2032. The U.S. led the North American market in 2023, generating revenue of USD 9.4 billion. The high incidence of chronic diseases, such as diabetes, cancer, and autoimmune disorders, is a significant factor driving demand in the region.

Regulatory oversight ensures that these products meet safety and labeling standards, further boosting consumer confidence in the efficacy and quality of the supplements available.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of chronic diseases
      • 3.2.1.2 Increasing health awareness
      • 3.2.1.3 Rising geriatric population
      • 3.2.1.4 Innovations in supplement formulations
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High costs associated with advanced supplements
      • 3.2.2.2 Potential side effects
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Future market trends
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Vitamins
    • 5.2.1 Vitamin A
    • 5.2.2 Vitamin B complex
    • 5.2.3 Vitamin C
    • 5.2.4 Vitamin D
    • 5.2.5 Vitamin E
    • 5.2.6 Vitamin K
  • 5.3 Mineral supplements
    • 5.3.1 Zinc supplements
    • 5.3.2 Iron supplements
    • 5.3.3 Magnesium supplements
    • 5.3.4 Other mineral supplements
  • 5.4 Herbal supplements
  • 5.5 Probiotic supplements
  • 5.6 Amino acids & proteins
  • 5.7 Omega 3 fatty acids
  • 5.8 Electrolyte supplements

Chapter 6 Market Estimates and Forecast, By Formulations, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Capsules
  • 6.3 Tablets
  • 6.4 Powder
  • 6.5 Liquid
  • 6.6 Other formulations

Chapter 7 Market Estimates and Forecast, By Source Type, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Natural
  • 7.3 Synthetic

Chapter 8 Market Estimates and Forecast, By Mode of Medication, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Prescription
  • 8.3 Over-the-counter (OTC)

Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 Offline retail stores
    • 9.2.1 Pharmacies & drug stores
    • 9.2.2 Hypermarkets/supermarkets
    • 9.2.3 Convenience stores
  • 9.3 Online retail stores

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Netherlands
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Argentina
  • 10.6 Middle East and Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 UAE

Chapter 11 Company Profiles

  • 11.1 Abbott Laboratories
  • 11.2 American Health
  • 11.3 Amway
  • 11.4 Bayer
  • 11.5 Cargill
  • 11.6 Danone
  • 11.7 Herbalife Nutrition of America
  • 11.8 Himalaya Global Holdings
  • 11.9 MegaFood
  • 11.10 Metagenics
  • 11.11 Nordic Naturals
  • 11.12 NOW Foods
  • 11.13 Nestle
  • 11.14 Swisse Wellness
  • 11.15 The Nature's Bounty